Results 111 to 120 of about 9,275 (242)
Structural basis for severe pain caused by mutations in the voltage sensors of sodium channel NaV1.7
Mutations in the voltage-gated sodium channel NaV1.7 cause the chronic pain syndrome, inherited erythromelalgia. Structures of bacterial sodium channel NaVAb with these mutations revealed changes that would enhance the outward movement of the gating ...
G. Wisedchaisri +4 more
semanticscholar +1 more source
PMP22 copy number variation disrupts myelin architecture at SLIs and Nodes of Ranvier. Adherens junction and axoglial domain defects are often more severe in CMT1A than HNPP. Findings support PMP22 functioning as a structural organizer of myelin. ABSTRACT Charcot–Marie–Tooth Disease Type 1A (CMT1A) and Hereditary Neuropathy with Liability to Pressure ...
Kathryn R. Moss +3 more
wiley +1 more source
Background: Functional deletion of the Scn9a (sodium voltage-gated channel alpha subunit 9) gene encoding sodium channel Nav1.7 makes humans and mice pain-free. Opioid signalling contributes to this analgesic state.
Vanessa Pereira +5 more
doaj +1 more source
Update of the statement on safety of cannabidiol as a novel food
Abstract During the assessment of cannabidiol (CBD) as a novel food, in 2022 the NDA Panel identified significant data gaps. Concerns focused on potential adverse effects on the liver, gastrointestinal tract, endocrine, nervous and reproductive systems.
EFSA Panel on Nutrition +33 more
wiley +1 more source
Risks for public health related to the presence of tetrodotoxin (TTX) and TTX analogues in marine bivalves and gastropods [PDF]
Peer reviewedPublisher ...
EFSA Panel on Contaminants in the Food Chain (CONTAM)
core +1 more source
Genetic studies have identified the voltage‐gated sodium channel 1.7 (Nav1.7) as pain target. Due to the ineffectiveness of small molecules and monoclonal antibodies as therapeutics for pain, single‐domain antibodies (VHHs) are developed against the ...
Marzia Martina +20 more
semanticscholar +1 more source
Objective There are no US Food and Drug Administration–approved therapies for Raynaud phenomenon (RP) in the United States. Clinical trials have been challenged by study design. Important advances in RP patient‐reported outcome measures and mechanistic quantification allow RP‐related pain characterization.
Tracy M. Frech +4 more
wiley +1 more source
Tailoring μ-Conotoxin-KIIIA to Selectively Inhibit NaV1.7 [PDF]
Voltage-gated sodium(NaV) channels are critical in initiating and propagating nerve impulses in a variety of tissues including, skeletal(NaV1.4) and cardiac(NaV1.5) muscle, brain(NaV1.2), and peripheral nerve(NaV1.7). Of special interest as a potential drug target is NaV1.7, which mediates propagation of pain signals from receptors to the CNS ...
McArthur, Jeff R. +5 more
openaire +1 more source
Ion channel recordings on an injection-molded polymer chip [PDF]
In this paper, we demonstrate recordings of the ion channel activity across the cell membrane in a biological cell by employing the so-called patch clamping technique on an injection-molded polymer microfluidic device.
Christensen, Mette Thylstrup +8 more
core +1 more source
Voltage‐gated sodium channels, including NaV1.7, NaV1.8, and NaV1.9, play important roles in pain transmission and chronic pain development. However, the specific mechanisms of their action remain unclear, highlighting the need for in vivo stimulation ...
Toyoaki Maruta +9 more
semanticscholar +1 more source

